The player is loading ...
Ne manquez rien des coulisses de Pharma minds ! Rejoignez ma newsletter pour recevoir des contenus exclusifs et toutes les nouveautés.
Eric Dessertenne is CEO of Biocorp, which has been acquired by Novo Nordisk in June 2023.
Biocorp develops and produces connected sensors, in particular for insulin pens.
Eric explains how he grabbed an opportunity.
The opportunity to join a founde...
Eric Dessertenne is CEO of Biocorp, which has been acquired by Novo Nordisk in June 2023.
Biocorp develops and produces connected sensors, in particular for insulin pens.
Eric explains how he grabbed an opportunity.
The opportunity to join a founder, an entrepreneur with whom he has built an exceptional history.
One of those moments in life when nothing predestined him to make this choice, right now.
He explains how he felt he had to take the plunge.
In the episode, he goes back over the stages of Biocorp's development into the company Novo Nordisk bought.
-
1. Working together
THE FARM & CO develops your visibility in Pharma using the strength of your therapeutic commitment, the uniqueness of your personality and the power of social networks. Build a presence aligned with your values. Ghostwriting, content creation & conversational tools.
2. My newsletter
In my newsletter Pharma futurista, 2x/month, I jump into our society's evolutions and apply them to the future of Pharma. It's a short, 3-minute read on a subject that appeals to me. To receive it, you can subscribe here: https://nathalielahitte.substack.com/ or directly on my LinkedIn profile.
3. Get in touch with me!
If you like the podcast, the best way to tell me or share your thoughts is on the Apple podcast app. It really helps me out, so don't hesitate to share!
If you'd like to ask me questions or follow my progress, you can do so on LinkedIn @nathalie lahitte .
